RecruitingPhase IInterventional

Deferred registration: Quotient Sciences code: QSC303996

This is an early-stage medical research study, known as a Phase I trial, involving healthy volunteers. Specifically, it's open to men aged between 25 and 55 years old. The main purpose of a Phase I trial is to test a new treatment for the first time in people, primarily to understand how safe it is and how it behaves in the body. At this very early stage, all the specific details of what the study involves aren't yet available to the public, but they will be released by a set date. These trials are crucial for developing new medicines, as they provide essential information before larger studies can begin.

At a glance

Status

Recruiting

Phase

Phase I

Sponsor

Orion Corporation (Finland)

Enrolment target

Start

15 May 2026

Estimated completion

10 Aug 2026

Healthy volunteers

What is this study about?

You've found information about a medical research study, which is an important step in developing new treatments. This particular study is called a 'Phase I' trial. Think of medical research for a new treatment like a journey with several stages. Phase I is the very first stage where a new treatment is tried in people.

The main goal of Phase I studies is to see if a new treatment is safe. Researchers will carefully check how the body handles the treatment, what side effects might occur, and how much of the treatment is needed. Because it's so early, these studies usually involve a small number of healthy volunteers, like the men aged 25-55 in this case.

All the specific details about this study, including exactly what participants will do and what the treatment is, aren't publicly available just yet. This is quite normal for very early-stage research. However, a promise has been made that all this information will be shared by a specific future date, so there's full transparency about the research.

Key takeaways

This is an early-stage study for a new treatment.
It involves healthy men aged 25 to 55 years old.
The primary goal is to check the treatment's safety.
Full study details will be released publicly soon.
Participation helps advance medical research.

Who may be eligible?

To take part in this study, you would need to be a healthy man, meaning you generally don't have any significant ongoing health problems.

You must also be within a specific age range, from 25 years old up to and including 55 years old.

At this early stage, the full list of who can and cannot join isn't public, but it's common for these studies to have very strict rules to keep participants safe and make sure the results are clear.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you a man?
Are you between 25 and 55 years old (inclusive)?
Are you generally in good health?
Are you able to commit to potential clinic visits and follow-ups?

Answer every question to see your result.

What does participation involve?

As this is an early-stage study, the full details of what taking part would involve aren't available yet. However, typically in a Phase I study, you can expect to visit the research clinic multiple times. These visits might include medical checks, blood tests, and receiving the study treatment. Some Phase I studies may involve staying at the clinic overnight for a period. Researchers will carefully monitor your health throughout the study to see how your body reacts to the treatment. The total duration of your involvement could range from a few days to several weeks, depending on the study design. You would be fully informed about all requirements before deciding to participate.

Potential risks and benefits

Participating in research studies always comes with potential benefits and risks. The main benefit for participants in Phase I studies is contributing to medical science and potentially helping to develop future treatments, which can be very rewarding. However, because the treatment is new, there's always a risk of unexpected side effects or reactions, some of which might be unpleasant or even serious. It's important to remember that you can always change your mind and withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Quotient Sciences Limited
Unverified
Nottingham, England

Common questions

What does 'Phase I trial' mean?

It's the very first stage of testing a new treatment in people, mainly to check if it's safe and how the body handles it, usually with healthy volunteers.

Why aren't all the details available yet?

It's common for very early-stage studies to keep some details private initially. All information will be shared publicly by a specific date.

What kind of people usually take part in Phase I studies?

Often, these studies look for healthy volunteers to get a clear picture of how a new treatment affects a healthy body before trying it in people with an illness.

Will I receive any treatment as part of this study?

Yes, if you participate, you will receive the new treatment being studied. The study's main aim is to observe its safety and effects.

Is there any financial compensation for taking part?

While not always the case, many studies, especially those involving healthy volunteers, offer payment for your time and travel. This information would be fully disclosed if you enquire about the study.

How to find out more

Clinical Study Director

clinicaltrials@orionpharma.com +358 10 4261 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.